Applications for the G4A Global Accelerator Are Now Open

Founded in 2013 in Berlin initially giving out grants to innovative healthcare apps, G4A Accelerator is now a global program dedicated to helping innovative health & care startups grow and enable positive disruption and progress within the digital health & care universe.

G4A Global Accelerator has two programs currently running for startups and companies. Join and change the experience of healthcare today. Accelerator applications close on May 31st!

G4A Accelerator

The 2018 Accelerator program aims to offer mentoring by entrepreneurs and Bayer experts, office space for 100 days, funding of 50,000€, and exclusive networking opportunities for your startup.

Over 100 Bayer experts are involved in the jury process to decide which companies Bayer will work with. Criteria of acceptance into the program include: company maturity, existing product prototypes, the team, as well as the applicant's fit to Bayer's areas of expertise and focus areas.

For further information and to apply, please visit:
https://bayer.agorize.com/en/challenges/g4a-global-accelerator-2018

G4A Dealmaker

The 2018 Dealmaker program is tailored for mature startups and companies that have a solution ready to go. The new Dealmaker is all about quality facetime between you and G4A experts for one full day. If there is a match, you will be invited to Berlin to pitch your solution, discuss collaboration options and close a deal. Travel stipends included!

For further information and to apply, please visit:
https://bayer.agorize.com/en/challenges/g4a-global-dealmaker-2018

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...